Rep., 8, 360-365 (2007).
8. Yan, J. et al., Oncogene, 18, 5850-5859 (1999).
9. Zhou, X. et al., Proc. Natl. Acad. Sci USA, 104,
5842-5847 (2007).
10. Hara, T. et al., J. Cell Biol., 181, 497-510 (
and L-lysine
stimulation on cultured human osteoblasts.
Biomed. Pharmacother., 56(10), 492-497 (2002).
8. Atkinson, M. R., et al., Activation of the glnA, glnK,
and nac promoters as Escherichia coli
L-arginine and L-lysine
stimulation on cultured human osteoblasts.
Biomed. Pharmacother., 56(10), 492-497 (2002).
6. Leitao, A. L., et al., Effect of exogenous lysine on
the expression of early cephamycin
, Y. et al., Muscle Nerve, 36, 497-504
(2007).
6. Izmiryan, A. et al., Exp. Cell Res., 10, 769-783
(2009).
7. Pan, Y. et al., FASEB J., 22, 3196-3206 (2008).
8. Uyama, N. et al., Gut
. Med. Biol. 95,
199 (1977).
3. Takahashi, K., and Chang, W. J., J. Biochem.
(Tokyo), 80, 497 (1976).
4. Dunn, B.M., in Proteolytic Enzymes: A Practical
Approach, R.J. Beynon and J.S.
and L-lysine
stimulation on cultured human osteoblasts.
Biomed. Pharmacother., 56(10), 492-497 (2002).
8. Atkinson, M. R., et al., Activation of the glnA, glnK,
and nac promoters as Escherichia
and L-lysine
stimulation on cultured human osteoblasts.
Biomed. Pharmacother., 56(10), 492-497 (2002).
8. Atkinson, M. R., et al., Activation of the glnA, glnK,
and nac promoters as Escherichia coli
Y. et al., Muscle & Nerve, 36, 497-504
(2007).
6. Izmiryan, A. et al., Exp. Cell Res., 10, 769-783
(2009).
7. Pan, Y. et al., FASEB J., 22, 3196-3206 (2008).
8. Uyama, N. et al., Gut
10:1652.
20. Ruoslahti, E. and Pierschbacher, M. (1987). Science 238:491-497.
21. Pierschbacher, M. and Ruoslahti, E. (1987). J. Biol. Chem. 262(36):17294-17298.
22. Cappello, J. and Crissman, J. (1990
10:1652.
20. Ruoslahti, E. and Pierschbacher, M. (1987). Science 238:491-497.
21. Pierschbacher, M. and Ruoslahti, E. (1987). J. Biol. Chem. 262(36):17294-17298.
22. Cappello, J. and Crissman, J. (1990
10:1652.
20. Ruoslahti, E. and Pierschbacher, M. (1987). Science 238:491-497.
21. Pierschbacher, M. and Ruoslahti, E. (1987). J. Biol. Chem. 262(36):17294-17298.
22. Cappello, J. and Crissman, J. (1990
10:1652.
20. Ruoslahti, E. and Pierschbacher, M. (1987). Science 238:491-497.
21. Pierschbacher, M. and Ruoslahti, E. (1987). J. Biol. Chem. 262(36):17294-17298.
22. Cappello, J. and Crissman, J. (1990
10:1652.
20. Ruoslahti, E. and Pierschbacher, M. (1987). Science 238:491-497.
21. Pierschbacher, M. and Ruoslahti, E. (1987). J. Biol. Chem. 262(36):17294-17298.
22. Cappello, J. and Crissman, J. (1990
10:1652.
20. Ruoslahti, E. and Pierschbacher, M. (1987). Science 238:491-497.
21. Pierschbacher, M. and Ruoslahti, E. (1987). J. Biol. Chem. 262(36):17294-17298.
22. Cappello, J. and Crissman, J. (1990
10:1652.
20. Ruoslahti, E. and Pierschbacher, M. (1987). Science 238:491-497.
21. Pierschbacher, M. and Ruoslahti, E. (1987). J. Biol. Chem. 262(36):17294-17298.
22. Cappello, J. and Crissman, J. (1990
and characterization of a
new site-specific endonuclease Eco RV" Dokl. Akad. Nauk SSSR
253, 495-497.
8 Nwosu, V.U. et al. (1988) "The cloning, purification and charac-
terization of the Eco RV modification
extracellular matrix proteins in vitro:
quantitative and qualitative investigation of
cytokeratin 7, 8 , 18, 19 and vimentin filaments. J.
Hepatol., 28, 677-690 (1998).
13. Toshima, J. Cofilin phosphorylation
DNA/ethidium bromide complex
(~ 0.15). The maximum excitation wavelength of
SYBR Green I is 497 nm, but there is also a secondary
excitation peak near 254 nm. The fluorescence
emission of SYBR
et al., Mol. Cell. Biol., 21, 2393-2403 (2001).
61. Horiba, M., et al., J. Clin. Invest., 105, 489-497 (2000).
62. Qi, M., et al., J. Biol. Chem., 276, 15868-15875 (2001).
63. Maeda, N., et al., J. Biol
of the DNA/ethidium bromide complex (∼0.15). The
maximum excitation wavelength of SYBR Green I is
497 nm, but there is also a secondary excitation peak
near 254 nm. The fluorescence emission of SYBR